Article Versions Notes

Gherardini L, Inzalaco G, Imperatore F, D’Aurizio R, Franci L, Miragliotta V, Boccuto A, Calandro P, Andreini M, Tarditi A, et al. The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models. Cancers. 2021; 13(19):4830. https://doi.org/10.3390/cancers13194830

Gherardini, Lisa, Giovanni Inzalaco, Francesco Imperatore, Romina D’Aurizio, Lorenzo Franci, Vincenzo Miragliotta, Adele Boccuto, Pierpaolo Calandro, Matteo Andreini, Alessia Tarditi, and et al. 2021. "The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models" Cancers 13, no. 19: 4830. https://doi.org/10.3390/cancers13194830

Gherardini, L., Inzalaco, G., Imperatore, F., D’Aurizio, R., Franci, L., Miragliotta, V., Boccuto, A., Calandro, P., Andreini, M., Tarditi, A., & Chiariello, M. (2021). The FHP01 DDX3X Helicase Inhibitor Exerts Potent Anti-Tumor Activity In Vivo in Breast Cancer Pre-Clinical Models. Cancers, 13(19), 4830. https://doi.org/10.3390/cancers13194830